Amphastar Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Amphastar Pharmaceuticals,

09/08/2021 21:59

* Amphastar Pharmaceuticals Inc  AMPH.OQ  reported quarterly
adjusted earnings of 21 cents​​ per share for the quarter ended
in June. The mean expectation of six analysts for the quarter
was for earnings of 21 cents per share.
* Revenue rose 18.5% to $101.66 million from a year ago; 
analysts expected $101.38 million. 
* Amphastar Pharmaceuticals Inc's reported EPS for the quarter
was 16 cents​.
* The mean earnings estimate of analysts had fallen by
about 2.8% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Amphastar Pharmaceuticals Inc shares had risen by 0.7% this
quarter and gained 1.0% so far this year.
* The company reported quarterly net income of $7.77 million.
* Wall Street's median 12-month price target for Amphastar
Pharmaceuticals Inc is $21.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," 4
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 9 at 08:59 p.m.  ​All
figures in US dollars unless otherwise stated